Toksanbayev Daniyar, Sadykov Nariman, Moldabekov Erman, Doskhanov Maxat, Duisebekov Maksat, Kaniyev Shokan
From Syzganov's National Scientific Center of Surgery, Zheltoksan st., 51, Almaty, 050004, The Republic of Kazakhstan.
Exp Clin Transplant. 2015 Nov;13 Suppl 3:41-3. doi: 10.6002/ect.tdtd2015.O26.
Patients with chronic end-stage liver disease present a significant problem in the Republic of Kazakhstan. The liver transplant program was started in December 2011 and for May 2015, more than 80 liver transplant operations have been performed in 7 different hospitals of the country.
The main problem that hinders the wide implementation of liver transplant in our country is poor development of regularity of deceased-organ donation system. This is because of the specific mentality of the population and imperfect legislation.
From 26 operated recipients, 19 lead a normal life (73.1%), receiving a minimal immunosuppressive therapy. In patients with cirrhosis of viral cause, there are no cases of viral hepatitis reinfection.
Preliminary findings based on a small experience showed a good perceptiveness of developing of Liver Transplant program in Kazakhstan.
慢性终末期肝病患者在哈萨克斯坦共和国是一个重大问题。肝脏移植项目于2011年12月启动,截至2015年5月,该国7家不同医院已进行了80多例肝脏移植手术。
阻碍我国肝脏移植广泛开展的主要问题是尸体器官捐赠系统的规则制定不完善。这是由于民众的特定心态和不完善的立法所致。
26例接受手术的受者中,19例(73.1%)在接受最低限度免疫抑制治疗的情况下过着正常生活。在病毒性肝硬化患者中,没有病毒肝炎再次感染的病例。
基于少量经验的初步结果表明,哈萨克斯坦肝脏移植项目的发展前景良好。